🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a dose-ranging study designed to investigate the efficacy and safet...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-12
Trial ID
NCT01490632
Treatments Being Tested
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
RV568 is being developed as a possible treatment of smoking related lung di...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01661244
This study is researching an experimental drug called ALN-APOC3 (called "st...
Status
Completed
Location
Arensia Exploratory Medicine at the Republican Clinical Hospital
Start Date
2025-01-27
Trial ID
NCT06784349
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
Multicenter, double-blind, randomized, placebo-controlled phase I/II study ...
Status
Recruiting
Location
Clinica Universidad de Navarra
Start Date
2020-03-11
Trial ID
NCT04163562
To investigate safety, tolerability, pharmacokinetics, pharmacodynamics and...
Status
Completed
Location
Fukuoka Clinical Site
Start Date
2019-09-12
Trial ID
NCT04079062
Treatments Being Tested
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
This study will test a study medicine called REGN20423 to see how effective...
Status
Recruiting
Location
Center for Clinical Pharmacology University Hospitals Leuven (UZ Leuven)
Start Date
2026-05-22
Trial ID
NCT07527923